Mitochondrial Replacement, Evolution, and The Clinic: Klaus Reinhardt, Damian K. Dowling, Edward H. Morrow
Mitochondrial Replacement, Evolution, and The Clinic: Klaus Reinhardt, Damian K. Dowling, Edward H. Morrow
MEDICINE
M
itochondrial diseases [often caused the United Kingdom, who suggested that available to couples at risk of having an
by mutations in mitochondrial MR will not affect characteristics normally affected child” (9). The results, published
DNA (mtDNA)] can manifest associated with individual identity (6). MR in March 2013, note general support within
in a range of severe symptoms, for which was compared with replacing the batteries the United Kingdom for permitting MR; if
there are currently no cures (1). The applied under strict regulation, such
diseases are passed from mothers to Health outcomes of intraspecies as case-by-case approval of licensed
offspring. Intense research efforts experimental mr in animals hospitals, ethical concerns about the
have recently focused on a germline implementation of MR were consid-
Studies using invasive techniques
therapeutic strategy to prevent the ered to be outweighed by arguments
inheritance of disease-causing mito- Human (Homo sapiens) in favor of MR (10). In June 2013,
Development to blastocyst stage
broadly denoted as mtDNA haplotypes. Puta- effects were naturally occurring, putatively In conclusion, recent technical advances
tively healthy mitochondrial haplotypes dif- healthy variants. Hundreds of mitochondrial- suggest that MR-assisted gene therapy could
fer in their effect on the expression of key sensitive nuclear genes identified in that study soon be available to help female sufferers of
health and performance parameters. In par- had a core role in male fertility. For example, mitochondrial diseases have healthy chil-
ticular, energy production critically hinges on one of the five combinations in which mito- dren, and this is clearly an exciting pros-
extensive cross-talk between genes dispersed chondrial-nucleus interactions were disrupted pect. Changing legislation that would facili-
across the nucleus and the mitochondria (12). by mismatching was completely male-ster- tate this technique will require a debate over
Because phenotypes with less-than-ideal ile but female-fertile (14). In other fly stud- the extent to which the results and principles
cross-talk are disfavored by natural selection, ies, MR resulted in male-biased modifica- outlined here are ethically and clinically rele-
coordinated mitochondrial-nuclear interac- tions to components of aging and affected vant to MR in humans. MtDNA diseases vary
tions become highly specific over evolution- the outcomes of in vivo male fertility (see from mild symptoms and learning disabilities
ary time. If MR disrupts such specific, highly the table). Together, these results suggest that to severe disabilities and premature death.
coordinated mito-nuclear allelic interactions, core components of male health depend on Assessing the costs and benefits of MR treat-
adverse health outcomes might occur. fine-tuned coordination between mitochon- ment requires that prospective patients are
This prediction is supported by experi- drial and nuclear gene complexes, and thus as fully informed as possible. The difference
mental studies reporting the expression of the HFEA conclusion that “there is no evi- across patients in the severity of expected off-
disease phenotypes when genetic backcross- dence for any mismatch between the nucleus spring symptoms in the event that MR treat-
ing was used to replace mitochondria and and any mtDNA haplogroup, at least within ment is not taken will shape the decision of
to create intergenomic mismatches in mice. a species” [(10), 6.17 on p. 17] is incomplete choosing the treatment versus waiting for the
SUPPLEMENTARY http://science.sciencemag.org/content/suppl/2013/09/18/341.6152.1345.DC1
MATERIALS
REFERENCES This article cites 10 articles, 2 of which you can access for free
http://science.sciencemag.org/content/341/6152/1345#BIBL
PERMISSIONS http://www.sciencemag.org/help/reprints-and-permissions
Science (print ISSN 0036-8075; online ISSN 1095-9203) is published by the American Association for the Advancement of
Science, 1200 New York Avenue NW, Washington, DC 20005. The title Science is a registered trademark of AAAS.
Copyright © 2013, American Association for the Advancement of Science